These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 38266660

  • 1. In vivo imaging of synaptic density in neurodegenerative disorders with positron emission tomography: A systematic review.
    Visser M, O'Brien JT, Mak E.
    Ageing Res Rev; 2024 Feb; 94():102197. PubMed ID: 38266660
    [Abstract] [Full Text] [Related]

  • 2. In vivo tau PET imaging in dementia: Pathophysiology, radiotracer quantification, and a systematic review of clinical findings.
    Hall B, Mak E, Cervenka S, Aigbirhio FI, Rowe JB, O'Brien JT.
    Ageing Res Rev; 2017 Jul; 36():50-63. PubMed ID: 28315409
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Synaptic vesicle protein 2A as a potential biomarker in synaptopathies.
    Heurling K, Ashton NJ, Leuzy A, Zimmer ER, Blennow K, Zetterberg H, Eriksson J, Lubberink M, Schöll M.
    Mol Cell Neurosci; 2019 Jun; 97():34-42. PubMed ID: 30796959
    [Abstract] [Full Text] [Related]

  • 11. Synaptic Loss in Spinocerebellar Ataxia Type 3 Revealed by SV2A Positron Emission Tomography.
    Chen Z, Liao G, Wan N, He Z, Chen D, Tang Z, Long Z, Zou G, Peng L, Wan L, Wang C, Peng H, Shi Y, Tang Y, Li J, Li Y, Long T, Hou X, He L, Qiu R, Chen D, Wang J, Guo J, Shen L, Huang Y, Ashizawa T, Klockgether T, Tang B, Zhou M, Hu S, Jiang H.
    Mov Disord; 2023 Jun; 38(6):978-989. PubMed ID: 37023261
    [Abstract] [Full Text] [Related]

  • 12. In vivo PET of synaptic density as potential diagnostic marker for cognitive disorders: prospective comparison with current imaging markers for neuronal dysfunction and relation to symptomatology - study protocol.
    Vanderlinden G, Carron C, Vandenberghe R, Vandenbulcke M, Van Laere K.
    BMC Med Imaging; 2024 Feb 12; 24(1):41. PubMed ID: 38347458
    [Abstract] [Full Text] [Related]

  • 13. Reduced Synaptic Density in Patients with Lewy Body Dementia: An [11 C]UCB-J PET Imaging Study.
    Andersen KB, Hansen AK, Damholdt MF, Horsager J, Skjaerbaek C, Gottrup H, Klit H, Schacht AC, Danielsen EH, Brooks DJ, Borghammer P.
    Mov Disord; 2021 Sep 12; 36(9):2057-2065. PubMed ID: 33899255
    [Abstract] [Full Text] [Related]

  • 14. Identification of pre-synaptic density networks using [11C]UCB-J PET imaging and ICA in mice.
    Akkermans J, Zajicek F, Miranda A, Adhikari MH, Bertoglio D.
    Neuroimage; 2022 Dec 01; 264():119771. PubMed ID: 36436710
    [Abstract] [Full Text] [Related]

  • 15. In vivo imaging of synaptic density with [11C]UCB-J PET in two mouse models of neurodegenerative disease.
    Xiong M, Roshanbin S, Rokka J, Schlein E, Ingelsson M, Sehlin D, Eriksson J, Syvänen S.
    Neuroimage; 2021 Oct 01; 239():118302. PubMed ID: 34174391
    [Abstract] [Full Text] [Related]

  • 16. Synaptic changes in psychiatric and neurological disorders: state-of-the art of in vivo imaging.
    Howes O, Marcinkowska J, Turkheimer FE, Carr R.
    Neuropsychopharmacology; 2024 Nov 01; 50(1):164-183. PubMed ID: 39134769
    [Abstract] [Full Text] [Related]

  • 17. Synthesis and in Vivo Evaluation of a Novel PET Radiotracer for Imaging of Synaptic Vesicle Glycoprotein 2A (SV2A) in Nonhuman Primates.
    Li S, Cai Z, Wu X, Holden D, Pracitto R, Kapinos M, Gao H, Labaree D, Nabulsi N, Carson RE, Huang Y.
    ACS Chem Neurosci; 2019 Mar 20; 10(3):1544-1554. PubMed ID: 30396272
    [Abstract] [Full Text] [Related]

  • 18. Assessment of Gray Matter Microstructure and Synaptic Density in Alzheimer's Disease: A Multimodal Imaging Study With DTI and SV2A PET.
    Silva-Rudberg JA, Salardini E, O'Dell RS, Chen MK, Ra J, Georgelos JK, Morehouse MR, Melino KP, Varma P, Toyonaga T, Nabulsi NB, Huang Y, Carson RE, van Dyck CH, Mecca AP.
    Am J Geriatr Psychiatry; 2024 Jan 20; 32(1):17-28. PubMed ID: 37673749
    [Abstract] [Full Text] [Related]

  • 19. Classics in Neuroimaging: Untangling the Role of Tau in Neurodegenerative Disorders Using Positron Emission Tomography.
    Witek JA, Brooks AF, Scott PJH.
    ACS Chem Neurosci; 2022 Oct 05; 13(19):2778-2783. PubMed ID: 36112411
    [Abstract] [Full Text] [Related]

  • 20. 18F-FDG PET Imaging in Neurodegenerative Dementing Disorders: Insights into Subtype Classification, Emerging Disease Categories, and Mixed Dementia with Copathologies.
    Minoshima S, Cross D, Thientunyakit T, Foster NL, Drzezga A.
    J Nucl Med; 2022 Jun 05; 63(Suppl 1):2S-12S. PubMed ID: 35649653
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.